Single-shot Johnson & Johnson coronavirus vaccine found to be 66 per cent effective in global trial
J&J plans to seek emergency use authorisation from the US Food and Drug Administration next week.
Full Article
Single-shot Johnson & Johnson coronavirus vaccine found to be 66 per cent effective in global trial
SBS
0 shares
1 views
You might like
Related news coverage
Covid-19: Johnson & Johnson's vaccine 66% effective in large global trial
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72 per cent in..
Khaleej Times